COMMUNIQUÉS West-GlobeNewswire

Decision on launch of voluntary offer
31/05/2018
Company announcement 31 May 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]
Offer youth intrauterine methods of contraception first, paediatricians advise
31/05/2018
OTTAWA, May 31, 2018 (GLOBE NEWSWIRE) -- Intrauterine methods of contraception should be the first-line birth control option for youth, according to a new position statement from the Canadian Paediatric Society (CPS) . [...]
Offrez d’abord des contraceptifs intra-utérins, conseillent les pédiatres
31/05/2018
OTTAWA, 31 mai 2018 (GLOBE NEWSWIRE) -- Selon un nouveau document de principes de la Société canadienne de pédiatrie , les contraceptifs intra-utérins devraient être proposés aux adolescentes avant toutes les autres [...]
Agility Health Reports 2017 Financial Results
31/05/2018
HAMILTON, Ontario , May 30, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“ Agility Health ” or “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services in Canada, today reported [...]
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
31/05/2018
SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (“ Arcturus ” or the “ Company ”) (NASDAQ: ARCT ), an RNA medicines company, today announced that the Extraordinary General Meeting of the [...]
Financial Results and Operational Highlights for the Third Quarter Ended March 31, 2018
31/05/2018
MELBOURNE, Australia and NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) today announced strong financial results for the nine months ended March 31, 2018 and provided operational [...]
Bradmer Announces First Quarter 2018 Financial Results
31/05/2018
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.H) (“Bradmer” or the “Company”) today announced its first quarter 2018 financial results. Financial Results Amounts in US dollars, [...]
Mesoblast Appoints New Chief Financial Officer
31/05/2018
MELBOURNE, Australia and NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) today announced the appointment of Josh Muntner as its new Chief Financial Officer, based in New York. [...]
Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
31/05/2018
THOROFARE, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that, on May 30, [...]
Helix BioPharma Corp. Completes Third Dosing Cohort and Initiates Enrollment of the Next Cohort in U.S. Combination Treatment Study of Its Lung Cancer Drug Candidate L-DOS47
30/05/2018
RICHMOND HILL, Ontario, May 30, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FSE:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Revive Therapeutics Announces Results for the Three and Nine Months Ended March 31, 2018
30/05/2018
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]
IMV Leadership to Participate in Upcoming Investor and Business Development Conferences
30/05/2018
HALIFAX, Nova Scotia, May 30, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX: IMV ) (OTCQX:IMMVD), a clinical stage immuno-oncology company, today announced details on upcoming industry presentations that the company’s [...]
AIT Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
30/05/2018
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients [...]
CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease
30/05/2018
BOSTON and ZUG, Switzerland and CAMBRIDGE, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) today announced that the U.S. Food and Drug [...]
Corvus Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference
30/05/2018
BURLINGAME, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
30/05/2018
MINNEAPOLIS, May 30, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP ) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Denali Therapeutics Announces Early Exercise of Its Option to Acquire F-star Gamma
30/05/2018
SOUTH SAN FRANCISCO, May 30, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, today [...]
Medigus to Present New Data On The MUSE™ System at Digestive Disease Week® (DDW) 2018
30/05/2018
OMER, Israel, May 30, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS ) (TASE: MDGS ), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, [...]
Golden Leaf Reports Fiscal First Quarter 2018 Results
30/05/2018
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]

Pages